We concluded that PDCD11 is an “Extra-nucleolar” oncoprotein to promote cancer cell growth and survival by regulation of G2/M checkpoint and DNA damage signaling, highlighting a potential novel target for treating CRC. The gene discussed is PDCD11; the disease is cancer.